Comorbilidad, medicación concomitante, uso de recursos y costes sanitarios asociados a los pacientes portadores del virus de la hepatitis C crónica en España-Reference-Cited by-同舟云学术

Comorbilidad, medicación concomitante, uso de recursos y costes sanitarios asociados a los pacientes portadores del virus de la hepatitis C crónica en España

Published:2018-04 Issue:4 Volume:41 Page:234-244
ISSN:0210-5705
Container-title:Gastroenterología y Hepatología
language:es
Short-container-title:Gastroenterología y Hepatología

Author:

Sicras-Mainar Antoni,Navarro-Artieda Ruth,Sáez-Zafra Marc

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference40 articles.

1. APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing;Omata;Hepatol Int.,2016

2. An update on the management of chronic hepatitis C: 2015 consensus guidelines from the Canadian Association for the Study of the Liver;Myers;Can J Gastroenterol Hepatol.,2015

3. Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy;Ansaldi;World J Gastroenterol.,2014

4. Epidemiology of hepatitis C in Europe;Negro;Dig Liver Dis.,2014

5. Hepatitis C virus infection in the older patient;Reid;Infect Dis Clin North Am.,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between hepatitis C virus infection status and blood pressure in adults in the United States: NHANES 1999–2012;Frontiers in Cellular and Infection Microbiology;2024-06-04

2. Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 years;Gastroenterología y Hepatología;2024-05

3. Riesgo de contagio por el deficiente manejo de Residuos Peligrosos Biológicos Infecciosos (RPBI´S) en México, debido a la falta de un procedimiento cuantitativo de identificación;LATAM Revista Latinoamericana de Ciencias Sociales y Humanidades;2023-03-02

4. Clinical and economic value of sofosbuvir-based regimens in the treatment of chronic hepatitis C in Spain;PLOS ONE;2022-12-01

5. The effect of hepatitis C—associated premature deaths on labour productivity losses in Spain: a ten-year analysis;The European Journal of Health Economics;2022-11-10